NeoGenomics, Inc. Net Income (Loss) Available to Common Stockholders, Basic
NeoGenomics, Inc. (NEO) reported Net Income (Loss) Available to Common Stockholders, Basic of -$25.92 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-04-29.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2025-04-29
- NeoGenomics, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2025-03-31 was -$25.92M.
- NeoGenomics, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2024-12-31 was -$15.32M.
- NeoGenomics, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2024-09-30 was -$17.70M.
- NeoGenomics, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2024-06-30 was -$18.64M.
- NeoGenomics, Inc. net income (loss) available to common stockholders, basic for fiscal 2024 was -$78.73M.
- NeoGenomics, Inc. net income (loss) available to common stockholders, basic for fiscal 2023 was -$87.97M.
- NeoGenomics, Inc. net income (loss) available to common stockholders, basic for fiscal 2022 was -$144.25M.
- NeoGenomics, Inc. net income (loss) available to common stockholders, basic for fiscal 2021 was -$8.35M, a 300.07% decline from fiscal 2020.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 3 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 12 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -$25.92M 10-Q · filed 2025-04-29 | -$41.25M derived: sum of 2 quarters · filed 2025-04-29 | -$58.95M derived: sum of 3 quarters · filed 2025-04-29 | -$77.59M derived: sum of 4 quarters · filed 2025-04-29 | ||||
| 2024-12-31 | -$15.32M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | -$33.02M derived: sum of 2 quarters · filed 2025-02-18 | -$51.66M derived: sum of 3 quarters · filed 2025-02-18 | -$78.73M 10-K · filed 2025-02-18 | ||||
| 2024-09-30 | -$17.70M 10-Q · filed 2024-11-05 | -$36.34M derived: sum of 2 quarters · filed 2024-11-05 | -$63.40M 10-Q · filed 2024-11-05 | -$77.73M derived: sum of 4 quarters · filed 2025-04-29 | ||||
| 2024-06-30 | -$18.64M 10-Q · filed 2024-07-30 | -$45.70M 10-Q · filed 2024-07-30 | -$60.03M derived: sum of 3 quarters · filed 2025-04-29 | -$78.55M derived: sum of 4 quarters · filed 2025-04-29 | ||||
| 2024-03-31 | -$27.06M 10-Q · filed 2025-04-29 | -$41.39M derived: sum of 2 quarters · filed 2025-04-29 | -$59.90M derived: sum of 3 quarters · filed 2025-04-29 | -$84.23M derived: sum of 4 quarters · filed 2025-04-29 | ||||
| 2023-12-31 | -$14.33M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | -$32.84M derived: sum of 2 quarters · filed 2025-02-18 | -$57.17M derived: sum of 3 quarters · filed 2025-02-18 | -$87.97M 10-K · filed 2025-02-18 | ||||
| 2023-09-30 | -$18.52M 10-Q · filed 2024-11-05 | -$42.85M derived: sum of 2 quarters · filed 2024-11-05 | -$73.64M 10-Q · filed 2024-11-05 | -$96.33M derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2023-06-30 | -$24.33M 10-Q · filed 2024-07-30 | -$55.13M 10-Q · filed 2024-07-30 | -$77.81M derived: sum of 3 quarters · filed 2025-02-18 | -$114.67M derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2023-03-31 | -$30.80M 10-Q · filed 2024-04-30 | -$53.48M derived: sum of 2 quarters · filed 2025-02-18 | -$90.33M derived: sum of 3 quarters · filed 2025-02-18 | -$125.64M derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2022-12-31 | -$22.69M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | -$59.54M derived: sum of 2 quarters · filed 2025-02-18 | -$94.84M derived: sum of 3 quarters · filed 2025-02-18 | -$144.25M 10-K · filed 2025-02-18 | ||||
| 2022-09-30 | -$36.85M 10-Q · filed 2023-11-06 | -$72.16M derived: sum of 2 quarters · filed 2023-11-06 | -$121.56M 10-Q · filed 2023-11-06 | -$163.32M derived: sum of 4 quarters · filed 2024-02-20 | ||||
| 2022-06-30 | -$35.30M 10-Q · filed 2023-08-08 | -$84.71M 10-Q · filed 2023-08-08 | -$126.47M derived: sum of 3 quarters · filed 2024-02-20 | -$146.82M derived: sum of 4 quarters · filed 2024-02-20 | ||||
| 2022-03-31 | -$49.41M 10-Q · filed 2023-05-09 | -$91.17M derived: sum of 2 quarters · filed 2024-02-20 | -$111.52M derived: sum of 3 quarters · filed 2024-02-20 | -$35.64M derived: sum of 4 quarters · filed 2024-02-20 | ||||
| 2021-12-31 | -$41.76M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | -$62.11M derived: sum of 2 quarters · filed 2024-02-20 | $13.77M derived: sum of 3 quarters · filed 2024-02-20 | -$8.35M 10-K · filed 2024-02-20 | ||||
| 2021-09-30 | -$20.35M 10-Q · filed 2022-11-08 | $55.52M derived: sum of 2 quarters · filed 2022-11-08 | $33.41M 10-Q · filed 2022-11-08 | $48.83M derived: sum of 4 quarters · filed 2023-02-24 | ||||
| 2021-06-30 | $75.87M 10-Q · filed 2022-08-09 | $53.76M 10-Q · filed 2022-08-09 | $69.18M derived: sum of 3 quarters · filed 2023-02-24 | $71.73M derived: sum of 4 quarters · filed 2023-02-24 | ||||
| 2021-03-31 | -$22.11M 10-Q · filed 2022-05-09 | -$6.70M derived: sum of 2 quarters · filed 2023-02-24 | -$4.14M derived: sum of 3 quarters · filed 2023-02-24 | -$10.96M derived: sum of 4 quarters · filed 2023-02-24 | ||||
| 2020-12-31 | $15.42M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $17.97M derived: sum of 2 quarters · filed 2023-02-24 | $11.15M derived: sum of 3 quarters · filed 2023-02-24 | $4.17M 10-K · filed 2023-02-24 | ||||
| 2020-09-30 | $2.56M 10-Q · filed 2021-11-04 | -$4.27M derived: sum of 2 quarters · filed 2021-11-04 | -$11.24M 10-Q · filed 2021-11-04 | -$4.95M derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-06-30 | -$6.82M 10-Q · filed 2021-08-09 | -$13.80M 10-Q · filed 2021-08-09 | -$7.51M derived: sum of 3 quarters · filed 2021-08-09 | -$5.36M derived: sum of 4 quarters · filed 2021-08-09 | ||||
| 2020-03-31 | -$6.98M 10-Q · filed 2021-05-06 | -$682.00K derived: sum of 2 quarters · filed 2021-05-06 | $1.46M derived: sum of 3 quarters · filed 2021-05-06 | $3.45M derived: sum of 4 quarters · filed 2021-05-06 | ||||
| 2019-12-31 | $6.30M 10-K · filed 2020-02-28 | $8.44M derived: sum of 2 quarters · filed 2020-10-29 | $10.43M derived: sum of 3 quarters · filed 2020-10-29 | $8.01M 10-K · filed 2022-02-25 | ||||
| 2019-09-30 | $2.14M 10-Q · filed 2020-10-29 | $4.13M derived: sum of 2 quarters · filed 2020-10-29 | $1.71M 10-Q · filed 2020-10-29 | $2.06M derived: sum of 4 quarters · filed 2020-10-29 | ||||
| 2019-06-30 | $1.99M 10-K · filed 2020-02-28 | -$433.00K 10-Q · filed 2019-08-07 | -$80.00K derived: sum of 3 quarters · filed 2020-02-28 | $1.94M derived: sum of 4 quarters · filed 2020-02-28 | ||||
| 2019-03-31 | -$2.42M 10-K · filed 2020-02-28 | -$2.07M derived: sum of 2 quarters · filed 2020-02-28 | -$48.00K derived: sum of 3 quarters · filed 2020-02-28 | $5.88M derived: sum of 4 quarters · filed 2020-02-28 | ||||
| 2018-12-31 | $353.00K 10-K · filed 2020-02-28 | $2.38M derived: sum of 2 quarters · filed 2020-02-28 | $8.30M derived: sum of 3 quarters · filed 2020-02-28 | $6.09M 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | $2.02M 10-K · filed 2020-02-28 | $7.95M derived: sum of 2 quarters · filed 2020-02-28 | $5.74M 10-Q · filed 2019-11-13 | $7.59M derived: sum of 4 quarters · filed 2020-02-28 | ||||
| 2018-06-30 | $5.92M 10-K · filed 2020-02-28 | $3.71M 10-Q · filed 2019-08-07 | $5.57M derived: sum of 3 quarters · filed 2020-02-28 | -$1.34M derived: sum of 4 quarters · filed 2020-02-28 | ||||
| 2018-03-31 | -$2.21M 10-K · filed 2020-02-28 | -$354.00K derived: sum of 2 quarters · filed 2020-02-28 | -$7.27M derived: sum of 3 quarters · filed 2020-02-28 | -$9.43M derived: sum of 4 quarters · filed 2020-02-28 | ||||
| 2017-12-31 | $1.86M 10-K · filed 2019-02-26 | $2.26M 10-K · filed 2018-03-13 | -$5.06M derived: sum of 2 quarters · filed 2019-02-26 | -$7.21M derived: sum of 3 quarters · filed 2019-02-26 | -$10.94M 10-K · filed 2020-02-28 | -$11.39M 10-K · filed 2018-03-13 | ||
| 2017-09-30 | -$6.92M 10-K · filed 2019-02-26 | -$7.75M 10-Q · filed 2017-11-13 | -$9.07M derived: sum of 2 quarters · filed 2019-02-26 | -$12.80M 10-Q · filed 2018-11-06 | -$13.65M 10-Q · filed 2017-11-13 | -$27.00M derived: sum of 4 quarters · filed 2019-02-26 | ||
| 2017-06-30 | -$2.16M 10-K · filed 2019-02-26 | -$2.68M 10-Q · filed 2017-08-07 | -$5.88M 10-Q · filed 2018-08-06 | -$5.90M 10-Q · filed 2017-08-07 | -$20.08M derived: sum of 3 quarters · filed 2019-02-26 | -$25.72M derived: sum of 4 quarters · filed 2019-02-26 | ||
| 2017-03-31 | -$3.73M 10-K · filed 2019-02-26 | -$3.22M 10-Q · filed 2017-05-09 | -$17.93M derived: sum of 2 quarters · filed 2019-02-26 | -$23.56M derived: sum of 3 quarters · filed 2019-02-26 | -$28.72M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2016-12-31 | -$14.20M 10-K · filed 2018-03-13 | -$19.83M derived: sum of 2 quarters · filed 2018-03-13 | -$24.98M derived: sum of 3 quarters · filed 2018-03-13 | -$30.82M 10-K · filed 2019-02-26 | -$30.40M 10-K · filed 2017-03-14 | |||
| 2016-09-30 | -$5.63M 10-K · filed 2018-03-13 | -$10.79M derived: sum of 2 quarters · filed 2018-03-13 | -$16.20M 10-Q · filed 2017-11-13 | -$17.80M derived: sum of 4 quarters · filed 2018-03-13 | ||||
| 2016-06-30 | -$5.15M 10-K · filed 2018-03-13 | -$10.56M 10-Q · filed 2017-08-07 | -$12.16M derived: sum of 3 quarters · filed 2018-03-13 | -$12.29M derived: sum of 4 quarters · filed 2018-03-13 | ||||
| 2016-03-31 | -$5.41M 10-K · filed 2018-03-13 | -$7.01M derived: sum of 2 quarters · filed 2018-03-13 | -$7.13M derived: sum of 3 quarters · filed 2018-03-13 | -$7.31M derived: sum of 4 quarters · filed 2018-03-13 | ||||
| 2015-12-31 | -$1.59M 10-K · filed 2017-03-14 | -$1.72M derived: sum of 2 quarters · filed 2017-03-14 | -$1.90M derived: sum of 3 quarters · filed 2017-03-14 | -$2.66M 10-K · filed 2018-03-13 | ||||
| 2015-09-30 | -$125.00K 10-K · filed 2017-03-14 | -$301.00K derived: sum of 2 quarters · filed 2017-03-14 | -$1.06M 10-Q · filed 2016-11-07 | |||||
| 2015-06-30 | -$176.00K 10-K · filed 2017-03-14 | -$937.00K 10-Q · filed 2016-08-05 | ||||||
| 2015-03-31 | -$761.00K 10-K · filed 2017-03-14 | |||||||
| 2014-12-31 | $1.13M 10-K · filed 2017-03-14 | |||||||
| 2013-12-31 | $2.03M 10-K · filed 2016-04-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |